Neuropharm neurology news

Neuropharm retained Piper Jaffray Ltd. to advise on a sale or merger of the biotech. Neuropharm also said it was in negotiations that may or may not lead to a sale of the company. Neuropharm will issue an update on the negotiations no later than at its annual general meeting Dec. 9. ...